Challenges in the management of checkpoint inhibitor induced liver injury

J Gastrointestin Liver Dis. 2023 Dec 22;32(4):560-562. doi: 10.15403/jgld-5401.

Authors

Adriana Cavasi¹, Irina Ștoleru², Maria Buziaș², Ioana Rusu²

Affiliations

¹ Prof. Octavian Fodor, Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca; Iuliu Hatieganu University of Gastroenterology and Hepatology, Cluj-Napoca, Romania. adi.cavasi@gmail.com.
² Prof. Octavian Fodor, Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania.

PMID: 38147609
DOI: 10.15403/jgld-5401

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents, Immunological* / adverse effects
Chemical and Drug Induced Liver Injury, Chronic*
Humans

Substances

Antineoplastic Agents, Immunological